oxis international inc (OXIS:OTC US)
oxis international inc (OXIS) Snapshot
|
Open
$0.01
|
Previous Close
$0.01
|
|
|
Day High
$0.01
|
Day Low
$0.01
|
|
|
52 Week High
05/21/12 - $0.03
|
52 Week Low
03/7/13 - $0.0051
|
|
|
Market Cap
4.7M
|
Average Volume 10 Days
16.0K
|
|
|
EPS TTM
$-0.01
|
Shares Outstanding
457.2M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
oxis international inc (OXIS) Related Businessweek News
No Related Businessweek News Foundoxis international inc (OXIS) Details
Oxis International, Inc. engages in the research, development, and sale of pharmaceutical products for the treatment of oxidative stress and inflammation. Its finished product and finished product candidates include therapeutic nutraceutical products, cosmeceutical products, functionals foods, and functional beverages. The company also provides proprietary compounds and formulations to biotech and pharmaceutical companies as drug candidates; EGT, a dietary supplement; and ErgoFlex, dietary supplement for the treatment of joint pain and restricted mobility. In addition, it offers personal care products, including skin care and cosmetic products; and veterinary products for companion animals, livestock, and performance animals, such as race horses. The company owns a range of trademarks, including ErgoFlex, Ergo-Plex, ERGOLD, Ergo-Max, Ergo-Pur, V[eye]tamin, and Immortal Energy, as well as a non-EGT related trademark Palosein. Oxis International, Inc. was founded in 1965 and is based in Beverly Hills, California.
oxis international inc (OXIS) Top Compensated Officers
oxis international inc (OXIS) Key Developments
On 04/01/2013, OXIS International Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
OXIS International Inc.will be added to CAC AllShares Index.
OXIS International Inc. reported revenue results for the third quarter of 2012. For the period, the company reported revenues were in excess of $110,000. This represents more than a 400% increase in revenues over all of 2011. The company expects significant revenue growth over the next few quarters resulting in a highly profitable 2013.
| Recently Viewed | |||
| OXIS:US | $0.01 USD | 0.00 |  |
| Company | Last | Change |
| Lifeway Foods Inc | $17.15 USD | -0.31 |
| Monster Beverage Corp | $56.27 USD | -0.64 |
| Nu Skin Enterprises Inc | $62.80 USD | +1.57 |
| Hain Celestial Group Inc/The | $66.97 USD | +0.11 |
| USANA Health Sciences Inc | $68.03 USD | +2.57 |
| View Industry Companies | ||
Industry Analysis
OXIS
Industry Average
| Valuation | OXIS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 32.5x |
|
| Price/Book | NM | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 16.6x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
To contact OXIS INTERNATIONAL INC, please visit www.oxis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
